Search results
Zydus Life shares gain on licensing agreement with Dr Reddy’s to market Pertuzumab Biosimilar
CNBC Awaaz· 1 hour agoZydus Lifesciences share price was up marginally percent in the opening trade on July 1 after the...
Dr Reddy's share price in focus on OTC brands acquisition
Livemint· 4 days agoGroup") to acquire consumer healthcare brands in the Nicotine Replacement Therapy category, outside...
Dr Reddy's shares zoom post Nicotinell acquisition; brokerages unimpressed
Business Standard India· 4 days agoOn Thursday, shares of the Dr Reddy's Laboratories zoomed up to 2.7 per cent at Rs 6,235.90 a piece...
Dr Reddy's shares: Should you buy, sell or hold the pharma stock after Nicotinell's acquisition?
Business Today· 3 days agoBrokerage firms continue to remain mostly positive on Dr Reddy's Laboratories Ltd as the pharma...
Dr Reddy’s Stock Rises After It Plans To Acquire Haleon’s Healthcare Brands For GBP 500 Million
Latest India News· 4 days agoThe business to be acquired from Haleon has maintained steady sales and strong profitability over...
Stock market today: Shares of L&T Tech Services, RVNL, Dr Reddy's, BLS International, and JSW Energy...
Firstpost· 4 days agoThe GIFT Nifty on Thursday suggested a negative start for D-Street. Global cues were mixed with US...
Top 10 Stocks In Focus Today: Titan, Reliance Industries, Vodafone Idea, Dr Reddy’s Laboratories,...
Latest India News· 4 days agoAurionpro Solutions Stock: Aurionpro Solutions shares are set to trade ex-bonus on June 27.
Stocks To Watch: Bharti Airtel, RVNL, Titagarh Rail, SBI, Dr Reddy’s, And Others - News18
News18· 4 days agoStocks to watch: Shares of firms like Bharti Airtel, RVNL, Titagarh Rail, SBI, Dr Reddy’s, and...
Brokerage Radar: Analysts cautious on Dr. Reddy's; Polycab target price upgraded
CNBC Awaaz· 4 days agoCheck out the latest brokerage calls and analyst comments on the stocks in action today. Our...
Hot Stocks: Brokerage view on Bharti Hexacom, Go Digit, PI Industries and Dr Reddy’s
The Economic Times· 4 days agoJefferies maintained an underperform rating on Dr Reddy’s Laboratories with a target price of Rs 5,010.